Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹316 Cr
P/E Ratio
--
P/B Ratio
4.67
Industry P/E
37.33
Debt to Equity
1.26
ROE
0.3 %
ROCE
6.03 %
Div. Yield
0 %
Book Value
69.65
EPS
-5.19
CFO
₹106.20 Cr
EBITDA
₹104.76 Cr
Net Profit
₹38.12 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Everest Organics
| 8.95 | 30.65 | 21.50 | 151.63 | 18.92 | 28.06 | -- |
|
BSE Healthcare
| -4.95 | 1.92 | -0.50 | 24.13 | 20.27 | 23.08 | 9.93 |
|
BSE Small Cap
| -10.08 | 4.17 | -3.87 | 5.97 | 18.98 | 35.50 | 15.85 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Everest Organics
| 136.21 | 2.68 | -50.48 | -12.61 | 68.52 | 64.03 | -25.46 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 426.15 | 7,122.13 | 25.96 | 12.5 | |
| 5,221.50 | 8,681.48 | 36.7 | 43.77 | |
| 721.80 | 7,088.86 | 80.29 | 4.01 | |
| 681.05 | 6,346.32 | 23.54 | 12.68 |
No Review & Analysis are available.
Everest Organics Limited manufactures and sells active pharmaceutical ingredients and intermediaries. The company also manufactures bulk drugs. It exports bulk drugs, intermediates, drug formulations, biologicals, Ayush and herbal, and surgical... products to the United States, Western Europe, Eastern Europe, South America, Egypt, Australia, Germany, Saudi Arabia, Dubai, China, Vietnam, Iran, Singapore, Indonesia, Bangladesh, Pakistan, Sri Lanka, and other Middle East countries. Everest Organics Limited was incorporated in 1993 and is based in Hyderabad, India. Read more
Incorporated
1993
Chairman
Ramakrishnam Raju Kounparaju
Managing Director
Srikakarlapudi Sirisha
Headquarters
Medak Dist, Telangana
Website
Looking for more details about Everest Organics Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsReceipt Of Trading Approval From BSE Limited
20-Mar-2025Receipt Of Listing Approval From BSE Limited
12-Mar-2025
The total asset value of Everest Organics Ltd stood at ₹ 220 Cr as on 31-Dec-24
The share price of Everest Organics Ltd is ₹328.00 (BSE) as of 24-Apr-2025 16:01 IST. Everest Organics Ltd has given a return of 18.92% in the last 3 years.
Everest Organics Ltd has a market capitalisation of ₹ 316 Cr as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Everest Organics Ltd is 4.67 times as on 24-Apr-2025, a 13% discount to its peers’ median range of 5.35 times.
Since, TTM earnings of Everest Organics Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Everest Organics Ltd and enter the required number of quantities and click on buy to purchase the shares of Everest Organics Ltd.
Everest Organics Limited manufactures and sells active pharmaceutical ingredients and intermediaries. The company also manufactures bulk drugs. It exports bulk drugs, intermediates, drug formulations, biologicals, Ayush and herbal, and surgical products to the United States, Western Europe, Eastern Europe, South America, Egypt, Australia, Germany, Saudi Arabia, Dubai, China, Vietnam, Iran, Singapore, Indonesia, Bangladesh, Pakistan, Sri Lanka, and other Middle East countries. Everest Organics Limited was incorporated in 1993 and is based in Hyderabad, India.
The prominent promoters of Everest Organics Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
VEERAT FINANCE INVESTMENT LIMITED |
38.37%
|
|
SRIHARI RAJU SRIKAKARLAPUDI |
12.76%
|
|
KRISHNA VENI SRIKAKARLAPUDI |
3.25%
|
The chairman of the company is Ramakrishnam Raju Kounparaju, and the managing director is Srikakarlapudi Sirisha.
There is no promoter pledging in Everest Organics Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,680
|
|
|
7,005
|
|
|
6,570
|
|
|
6,016
|
| Everest Organics Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-9.61
|
|
Operating margin(%)
|
0.29
|
|
Net Margin(%)
|
-2.41
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Everest Organics Ltd was ₹-4 Cr.
₹15.45
(
